Targeting transcription factors for cancer prevention--the case of Nrf2.
Colburn
Nancy H
NH
Laboratory of Cancer Prevention, National Cancer Institute, Frederick, Maryland 21702-1201, USA. Colburn@ncifcrf.gov
Kensler
Thomas W
TW
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use; D018450:Disease Progression; D016503:Drug Delivery Systems; D015972:Gene Expression Regulation, Neoplastic; D051379:Mice; D018345:Mice, Knockout; D051267:NF-E2-Related Factor 2 / Q000037:antagonists & inhibitors* / Q000235:genetics / Q000502:physiology; D009369:Neoplasms / Q000178:diet therapy / Q000517:prevention & control*; D014157:Transcription Factors / Q000037:antagonists & inhibitors* / Q000235:genetics
D000970:Antineoplastic Agents; D000972:Antineoplastic Agents, Phytogenic; D051267:NF-E2-Related Factor 2; D014157:Transcription Factors